MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
Alnylam Pharmaceuticals Total Inventories 2011-2026 | ALNY
Annual Total Inventories Alnylam Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.7 M | 78.5 M | 89.1 M | 129 M | 86.4 M | 75.2 M | 56.3 M | 24.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 129 M | 24.1 M | 77.7 M |
Quarterly Total Inventories Alnylam Pharmaceuticals
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.7 M | 65.6 M | 78.5 M | 76 M | 84 M | 94 M | 89.1 M | 95.8 M | 100 M | 132 M | 129 M | 115 M | - | 78.5 M | 86.4 M | 97.9 M | 84.4 M | 73.9 M | 75.2 M | 75.2 M | 75.2 M | 75.2 M | 56.3 M | 56.3 M | 56.3 M | 56.3 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 132 M | 24.1 M | 75 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerus Corporation
CERS
|
56.1 M | $ 2.72 | 33.99 % | $ 518 M |  USA |
 |
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 21.95 | -2.23 % | $ 3.64 B | USA |
 |
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | USA |
 |
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | USA |
 |
Caladrius Biosciences
CLBS
|
1.27 M | - | -16.75 % | $ 25.8 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
21.2 M | - | - | $ 2.18 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
70.1 M | - | - | $ 2.02 B | USA |
 |
Edesa Biotech
EDSA
|
224 K | $ 17.59 | -3.75 % | $ 56.2 M | USA |
 |
Eiger BioPharmaceuticals
EIGR
|
1.56 M | - | -9.21 % | $ 2.55 M | USA |